SIDEBAR


Get Permission

As of the ONS Annual Congress, three patients at Memorial Sloan-Kettering Cancer Center had been successfully treated in the outpatient setting with genetically modified T cell therapy, without major events or readmissions to the hospital, reported study author Cheryl Caravano, RN. Ms. Caravano hopes that her study will serve as a model for oncology nurses involved in using T-cell treatment for CLL.

Related Articles

Genetically Modified T-cell Therapy for Patients with CLL: The Role of the Oncology Nurse

Quality nursing and ongoing education are critical for success in using gene-modified T-cell therapy for patients with chronic lymphocytic leukemia (CLL), said Cheryl Caravano, RN, at the recent Annual Congress of the Oncology Nursing Society.  Ms. Caravano is a clinical nurse IV at Memorial...


Advertisement

Advertisement



Advertisement